Search

9.00 Decision making in a crisis situation
9.30 Developing confident leadership at all levels
10.30 Positive onboarding – making staff induction an investment for success
Sue Alexander, Royal Marsden NHS Foundation Trust
11.00 Lead, follow or get out of the way Glenn Noel-Storr, Royal Marsden NHS Foundation Trust, Chelsea
11.30 Applying organisation values to your leadership Sue Alexander, Royal Marsden NHS Foundation Trust

Chair: Ian Cocking
9.00 What the future holds in Microbiology - precision AMR project Francis Yongblah, Great Ormand Street Hospital for Children NHS Foundation Trust
9.30 Narrative Authorising -an extend role for biomedical scientists
Dr Michael Simmons, Public Health Wales
10.30 Advanced Clinical Practice in Microbiology Greg Williams, Public Health Wales
11.00 Long term quality improvement in microbiology
Matt O’Dwyer, University Hospital Southampton NHS Foundation Trust
11.30 Methods for the isolation of nontuberculous
mycobacteria (NTM) from respiratory samples and the environment Prof. John Perry, Newcastle upon
Tyne Hospitals NHS Foundation Trust

Chair: Matthew O’Dwyer
9.00 HSST experience in Microbiology
Phillipa Burns, Hull University Teaching Hospitals NHS Trust
9.30 A drive for change: a Queen’s Medical Centre perspective Bhavin Mistry, Nottingham University Hospitals NHS Trust
10.30 From Acrophialophora to Zygosaccharomyces: Expanding the potential of the Bruker Biotyper for fungal identification
Dr Mark Fraser, UK National Mycology Reference Laboratory, UK Health Security Agency
11.00 Rapid identification from blood cultures
Robert Impey, Portsmouth University Hospitals Trust
11.30 The microbiome and mental health
- potential future diagnostics in microbiology Matthew Fairbrother, University Hospitals of
Derby and Burton NHS Foundation Trust

Chair: Jessica Jones
9.00 Managing
O-negative red cells in hospital transfusion laboratories
Jill Caulfield, NHSBT
9.30 Ensuring continuity of the blood supply to English hospitals during the COVID-19 pandemic
Dean Neill, NHSBT
10.30 Managing hospital transfusion during a pandemic Karen Madgwick, North Middlesex University Hospital NHS Trust
11.00 Introduction of a new blood component Michael Wiltshire, NHSBT
11.30 Did convalescent plasma work in COVID patients?
Professor Lise Estcourt, NHSBT

Chair: Mike Palmer
9.00 Major Haemorrhage – a
laboratory perspective Newcastle Hospitals
NHS Foundation Trust
9.20 How electronic requesting systems for blood products like ICE could be utilised to reduce incidences of TACO
Natalie Hennessy, Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust
09.40 HDFN caused by Anti-K
Gemma Harte, Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust
10.30 Blood group – Kidd
Martin Maley, University of Sunderland
11.00 Blood Group – MNSs
Dr Tom Bullock, Red Cell
Immunohaematology - NHSBT
11.30 International Blood Group Reference Laboratory (IBGRL)
– finding new blood group antigens Shane Grimsley, International Blood Group Reference Laboratory - NHSBT
12.45 Antibody workshop
Jill Caulfield, NHSBT and Martin Maley, University of Sunderland

09.00 Pathology GIRFT: Next steps and implementing the recommendations
Dr Martin Myers, Dr Marion Wood and Tom Lewis, NHS England & Improvement
09.30 Pathology Quality Assurance Dashboard: The early years Jane Mills and Bruce Daniel, NHS England & Improvement
10.30 UKAS Update: The current challenges and opportunities
Lorraine Turner, UKAS
11.00 Accreditation to support the pandemic response- Private providers of covid 19 sampling and testing
Alyson Bryant, UKAS
11.30 Optimising UKAS Assessments
John Ringrow, UKAS

Chair: Dr Alistair Gammie 9.00 New Strategies or new diseases – capacity building Laura Ryall, UK Health Security Agency
9.30 New strategies for new diseases – crowdsourcing to resolve problems Prof. Jo Martin, NHS England and NHS Improvement
10.30 Pandemic response – from zero to 1 million tests
a day. Innovation, lessons learned and legacy
Melanie Smith, National Infection Service, UK Health Security Agency
11.00 Pandemic response – impact on vaccination programme and virus resurgence
Dr Kevin Brown, UK Health Security Agency
11.30 Pandemic response and impact
– economic impact on research and scientific development
Dr Bethan Hussey, Wellcome Sanger Institute

Chair: Jonathan Evans 9.00 Caring for the UKs first COVID-19 patients
Dr Richard Capstick, South Tyneside and Sunderland NHS Foundation Trust
9.20 The June Almeida COVID-19 laboratory set up: lessons learnt Bamidele Farinre, Viapath Analytics, An NHS partnership with SYNLAB
9.40 Hepatitis C - West Midlands Test & Treat Roadshow Philippe Bonnet, Hepatitis C Trust
Outbreak control
10.30 Tattoo and Piercing Infection Cases
Deborah Fenelon, UK Health Security Agency
11.00 COVID-19 - local outbreak control Owen Seddon, Public Health Wales
11.30 Outbreak control: Value of epidemiology & whole-genome sequencing Derren Ready, UK
Health Security Agency

13.00 Introduction
Chantel Hodgson, UK NEQAS Cellular Pathology Technique
13.30 Upper and lower GI Christopher Irving, Gloucestershire Hospitals NHS Foundation Trust
14.15 Gynaecological case studies Kirstie Rice, Black Country Pathology Services, The Royal Wolverhampton Hospital Trust and Gary Player, University Hospital of North Durham
15.45 Skin case studies
Dr Guy Orchard, Viapath Analytics, An NHS Partnership with SYNLAB
16.15 Fluid, Respiratory, Urology case studies
Dr Behdad Shambayati, Berkshire and Surrey Pathology Services
16.45 Breast case studies
Patrick Kumah, University Hospitals of Derby and Burton NHS Foundation Trust

Chair: Poonam Singh
9.00 Silver stains
– shining throughout the years
Al-Amara Rafique, UK NEQAS Cellular Pathology Technique
9.30 Disease models and quantitative pathology in liver research
Dr Tim Kendall, Royal Infirmary of Edinburgh
10.30 Case studies
– lung carcinoma & cholangitis
Maria Cunningham
11.00 Case studies – LLETZ and gallbladder Jemma Morris, Calderdale and Huddersfield NHS Foundation Trust
11.30 Best practice
– andrology David Sanders, United Kingdom
Accreditation Service